...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Questrade

Jan 05, 2024 09:54AM

Jan 05, 2024 11:37AM
1
Jan 05, 2024 12:41PM

Jan 05, 2024 01:22PM
2
Jan 05, 2024 11:25PM

"Something weird going on, in my opinion"

Truer words couldn't be said in regards to either of these company's imo.


Jan 07, 2024 06:30PM
Share
New Message
Please login to post a reply